Literature DB >> 27340741

Basosquamous Carcinoma: Controversy, Advances, and Future Directions.

Caroline Z Tan1, Kerri E Rieger, Kavita Y Sarin.   

Abstract

BACKGROUND: Basosquamous carcinoma is a rare cutaneous neoplasm that has caused considerable controversy as to its classification, pathogenesis, and management.
OBJECTIVE: To review and summarize current literature on the definition, pathogenesis, incidence, and management of basosquamous carcinoma.
MATERIALS AND METHODS: Through December 2015, an electronic search of the Pubmed database was performed using combinations of basosquamous carcinoma and metatypical basal cell carcinoma as search terms.
RESULTS: A selection of 39 publications including case reports and series, retrospective studies, and systematic reviews of the literature were included. Descriptions of the definition of basosquamous carcinoma, clinical behavior, histopathological characteristics, current treatment therapies, and future advances are summarized.
CONCLUSION: This systematic review provides a comprehensive overview of the current understanding of basosquamous carcinoma. Further study is required to elucidate the mechanisms driving the formation of this aggressive tumor.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27340741     DOI: 10.1097/DSS.0000000000000815

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  8 in total

1.  Characterization of Basosquamous Cell Carcinoma: A Distinct Type of Keratinizing Tumour.

Authors:  Giulio Gualdi; Simone Soglia; Marta Fusano; Paola Monari; Federica Giuliani; Annamaria Porreca; Marta Di Nicola; Piergiacomo Calzavara-Pinton; Paolo Amerio
Journal:  Acta Derm Venereol       Date:  2021-01-04       Impact factor: 3.875

2.  Basosquamous Carcinoma: A Single Centre Clinicopathological Evaluation and Proposal of an Evidence-Based Protocol.

Authors:  Jordan W Oldbury; Richard A J Wain; Sameera Abas; Christopher M Dobson; Srinivasan S Iyer
Journal:  J Skin Cancer       Date:  2018-06-03

3.  Combination of squamous cell carcinoma and basal cell carcinoma arising from a giant verruca vulgaris involving the eyelid.

Authors:  Kenneth Ka Hei Lai; Edwin Chan; SimonT C Ko
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-05

4.  c-FOS drives reversible basal to squamous cell carcinoma transition.

Authors:  François Kuonen; Nancy Yanzhe Li; Daniel Haensel; Tiffany Patel; Sadhana Gaddam; Laura Yerly; Kerri Rieger; Sumaira Aasi; Anthony E Oro
Journal:  Cell Rep       Date:  2021-10-05       Impact factor: 9.423

5.  Basosquamous Carcinoma: A Commentary.

Authors:  Christina Fotiadou; Zoe Apalla; Elizabeth Lazaridou
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

6.  Detection of Felis catus papillomavirus type 2 within multicentric basosquamous carcinoma in a domestic cat.

Authors:  Ye-In Oh; Doo-Sung Cheon; Jung-Keun Lee; Mi-Hyun Choi; Sun-Young Hwang; Hyun-Wook Kim; Byung-Jae Kang; Hwa-Young Youn
Journal:  J Vet Med Sci       Date:  2018-07-11       Impact factor: 1.267

Review 7.  Non-Melanoma Skin Cancers: Biological and Clinical Features.

Authors:  Mauro Cives; Francesco Mannavola; Lucia Lospalluti; Maria Chiara Sergi; Gerardo Cazzato; Elisabetta Filoni; Federica Cavallo; Giuseppe Giudice; Luigia Stefania Stucci; Camillo Porta; Marco Tucci
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

8.  Clinical and epidemiological analysis of basosquamous carcinoma: results of the multicenter study.

Authors:  Magdalena Ciążyńska; Martyna Sławińska; Grażyna Kamińska-Winciorek; Dariusz Lange; Bogumił Lewandowski; Adam Reich; Marta Pabianek; Katarzyna Szczepaniak; Adam Hankiewicz; Małgorzata Ułańska; Jan Morawiec; Maria Błasińska-Morawiec; Zbigniew Morawiec; Janusz Piekarski; Robert Brodowski; Anna Zaryczańska; Michał Sobjanek; Witold Owczarek; Monika Słowińska; Katarzyna Wróbel; Andrzej Bieniek; Anna Woźniacka; Małgorzata Skibińska; Joanna Narbutt; Wojciech Niemczyk; Karol Ciążyński; Aleksandra Lesiak
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.